Related by context. Frequent words. (Click for all words.) 71 Initiates Phase II 71 R sorafenib tablets 68 phenylalanine ammonia lyase 68 phase IIb clinical 68 Locteron ® 68 Daclizumab 67 Nexavar ® 67 PLK1 SNALP 67 Completes Enrollment 67 PEG PAL PEGylated recombinant 67 Tesetaxel 67 inhaled formulation 67 TELINTRA 67 Panzem R 67 GVAX R 66 Receives Orphan Drug Designation 66 Inc. Nasdaq IMGN 66 MKC# 66 Advancing Drugs 66 Inc Therapeutic Competitors 66 SAR# [004] 65 Genitope Corporation 65 Initiate Phase 65 Commences Phase 65 Allovectin 7 R 65 candidates bavituximab 65 Meets Primary Endpoint 65 AEG# 65 deforolimus 65 refractory chronic lymphocytic 65 Pivotal Phase III 65 confirmatory Phase III 65 Pivotal Phase 65 Initiates Phase 65 liposomal formulation 65 Presents Positive 64 Factor VIIa 64 Nasdaq ENMD 64 vosaroxin 64 developing Zerenex TM 64 NASDAQ LGND 64 Asentar 64 multi kinase inhibitor 64 TOCOSOL Paclitaxel 64 Soliris TM eculizumab 64 subcutaneous formulation 64 candidate brentuximab vedotin 64 proteasome inhibitor 64 Entereg R 64 metastatic castration resistant 64 forodesine 64 drug conjugate 64 Voreloxin 64 Ixempra 63 NEBIDO R 63 Inc. Nasdaq VVUS 63 ApoB SNALP 63 topical anti infective 63 Takeda Kyowa Hakko Kirin 63 elotuzumab 63 Cerimon 63 Rebif ® 63 HGS ETR1 63 MEK inhibitor 63 Pharmion Corporation 63 Bicifadine 63 Copegus R 63 TELCYTA 63 Kuvan R 63 anticancer compound 63 Phase III Clinical Trial 63 cancer immunotherapies 63 CDP# 63 Nasdaq ALTH 63 FavId 63 Dapagliflozin 63 Phase IIb trials 63 RH1 63 Pivotal Trial 63 Onalta 63 KNS # 62 R bortezomib 62 Chemokine Therapeutics 62 www.allos.com 62 factor VIIa 62 Phase 2b clinical trials 62 generation antisense 62 registrational trial 62 JAK1 62 Hybridon 62 inflammatory autoimmune diseases 62 GRNVAC1 62 PEG SN# 62 Icatibant 62 phenylketonuria PKU developed 62 dipropionate 62 HCV protease inhibitor 62 RGB # 62 MNTX 62 Pivotal Study 62 HGS ETR2